Clinical sequelae include CVD, metabolic disorders, and neurocognitive disorders as dysbiosis is associated with inflammaging, the chronic low-grade inflammation that accelerates atherosclerosis, insulin resistance and cognitive decline
Mechanism Behind GLP-1 RAs Kidney Protection A unique aspect of GLP-1 receptor agonists lies in their ability to reduce oxidative stress, a process that, when unchecked, can accelerate kidney damage in diabetic patients
GLP-1 Receptor agonists and kidney protection
While many people get enough B12 from their food, others benefit from Vitamin B12 injections to fix a deficiency or boost their health
Introduction Today, GLP-1 drugs are most commonly used for diabetes and weight loss, but there is potential for GLP-1 therapies to transform healthcare by offering new solutions for managing chronic conditions